tradingkey.logo
搜尋

Amneal Pharmaceuticals Inc

AMRX
添加自選
17.310USD
+0.020+0.12%
收盤 06/30, 16:00美東報價延遲15分鐘
5.52B總市值
44.64本益比TTM

Amneal Pharmaceuticals Inc

17.310
+0.020+0.12%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.12%

5天

+7.45%

1月

+31.44%

6月

+34.39%

今年開始到現在

+37.38%

1年

+112.92%

關鍵數據
17.300今開
17.490最高
2.26M成交量
44.64本益比TTM
13.96本益比動
--股利TTM
0.71%換手率
17.290昨收
17.170最低
31.71M成交額
虧損本益比靜
-121.60市淨率
0.00%股息率 TTM
5.25%ROA
15.42052週最高
0.66量比
-116.89M淨利潤
319.00M總股本
0.3877每股盈餘TTM
1.31Beta
-155.38%ROE
7.07052週最低
1.85%振幅
44.31%毛利率
5.52B總市值
17.72回報/風險
1.92%風險率

TradingKey Amneal Pharmaceuticals Inc股票評分

單位: USD 更新時間: 2026-06-29

操作建議

Amneal Pharmaceuticals Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名32/157位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為17.25。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Amneal Pharmaceuticals Inc評分

相關信息

行業排名
32 / 157
全市場排名
85 / 4570
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Amneal Pharmaceuticals Inc亮點

亮點風險
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
業績高增長
公司營業收入穩步增長,連續3年增長26.12%
業績轉盈
公司業績轉盈,最新年度盈利美元
估值合理
公司最新PE估值44.59,處於3年歷史合理位
機構減倉
最新機構持股161.64M股,環比減少13.73%
活躍度增加
近期活躍度增加,過去20天平均換手率0.36

分析師目標

基於 4 分析師
買入
評級
17.250
目標均價
-0.23%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Amneal Pharmaceuticals Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Amneal Pharmaceuticals Inc簡介

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
公司代碼AMRX
公司Amneal Pharmaceuticals Inc
CEOPatel (Chintu)
網址https://amneal.com/

常見問題

Amneal Pharmaceuticals Inc(AMRX)的當前股價是多少?

Amneal Pharmaceuticals Inc(AMRX)的當前股價是 17.29。

Amneal Pharmaceuticals Inc 的股票代碼是什麼?

Amneal Pharmaceuticals Inc的股票代碼是AMRX。

Amneal Pharmaceuticals Inc股票的52週最高點是多少?

Amneal Pharmaceuticals Inc股票的52週最高點是15.42。

Amneal Pharmaceuticals Inc股票的52週最低點是多少?

Amneal Pharmaceuticals Inc股票的52週最低點是7.07。

Amneal Pharmaceuticals Inc的市值是多少?

Amneal Pharmaceuticals Inc的市值是5.52B。

現在Amneal Pharmaceuticals Inc(AMRX)的股票是買入、持有還是賣出?

根據分析師評級,Amneal Pharmaceuticals Inc(AMRX)的總體評級為買入,目標價格為17.25。

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是多少

Amneal Pharmaceuticals Inc(AMRX)股票的每股收益(EPS TTM)是0.23。
KeyAI